» Articles » PMID: 39119412

Insulin Autoimmune Syndrome: A Case Report Highlighting Diagnostic Pitfalls

Overview
Journal Cureus
Date 2024 Aug 9
PMID 39119412
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin autoimmune syndrome (IAS) is characterized by spontaneous hyperinsulinemic hypoglycemia and the presence of insulin autoantibodies in high titers without exogenous insulin use. The C-peptide level during a hypoglycemia episode is useful for differentiating spontaneous hypoglycemia. Generally, low C-peptides are suspicious for exogenous insulin administration. We report a 47-year-old male nurse who presented with an initial episode of hypoglycemia. Despite the pattern of hyperinsulinemic hypoglycemia and low C-peptide, he was diagnosed with IAS based on the presence of insulin autoantibodies. This case underscores the importance of suspecting IAS in non-diabetic adults with hypoglycemia, even in the setting of low C-peptide levels.

References
1.
Ismail A . The double whammy of endogenous insulin antibodies in non-diabetic subjects. Clin Chem Lab Med. 2008; 46(2):153-6. DOI: 10.1515/CCLM.2008.031. View

2.
Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K . Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol. 2000; 61(2):154-7. DOI: 10.1016/s0198-8859(99)00144-5. View

3.
Saxon D, McDermott M, Michels A . Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2016; 101(5):1931-4. DOI: 10.1210/jc.2016-1097. View

4.
Cappellani D, Sardella C, Campopiano M, Falorni A, Marchetti P, Macchia E . Spontaneously remitting insulin autoimmune syndrome in a patient taking alpha-lipoic acid. Endocrinol Diabetes Metab Case Rep. 2018; 2018. PMC: 6300855. DOI: 10.1530/EDM-18-0122. View

5.
Lin M, Chen Y, Ning J . Insulin Autoimmune Syndrome: A Systematic Review. Int J Endocrinol. 2023; 2023:1225676. PMC: 9946739. DOI: 10.1155/2023/1225676. View